GlassScriptPhysician profile
Elizabeth Y Leon
NPI 1013022771
$951.42
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $34.41 · 2021: $164 · 2022: $225 · 2023: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $133.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $163.62 | 2019 | |
| Supernus Pharmaceuticals, INC. | $153.06 | 2021-2022 | |
| Pfizer INC. | $150.69 | 2019-2023 | |
| Tris Pharma INC | $92.94 | 2022 | |
| Corium, LLC | $72.06 | 2022-2023 | Azstarys |
| Cranial Technologies, INC | $61.69 | 2019-2023 | Doc Band |
| Viiv Healthcare Company | $59.51 | 2019-2020 | |
| Genentech USA, INC. | $54.93 | 2021-2022 | |
| Glaxosmithkline, LLC. | $41.80 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $32.01 | 2019 | |
| Nestle Healthcare Nutrition INC. | $27.48 | 2023 | |
| Alk-Abello, INC | $21.12 | 2023 | Grastek, Odactra, Ragwitek |
| Sanofi Pasteur INC. | $20.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.